Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria (Q67970228)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

title

Combination effect of SCE-2787 and cefepime with aminoglycosides on nosocomial gram-negative bacteria (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

author name string

J Hübner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

D Hartung

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

A Kropec

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

F D Daschner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

publication date

1 May 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

20 September 2019

page(s)

186-189

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1889877%20AND%20SRC:MED&resulttype=core&format=json

In vitro studies of BMY-28142, a new broad-spectrum cephalosporin

20 September 2019

cites work

1 reference

12 December 2020

Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy

1 reference

12 December 2020

In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus

1 reference

12 December 2020

In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin

1 reference

12 December 2020

Activity of cefepime against ceftazidime- and cefotaxime-resistant gram-negative bacteria and its relationship to beta-lactamase levels

1 reference

12 December 2020

Comparison of a new cephalosporin, BMY 28142, with other broad-spectrum beta-lactam antibiotics

1 reference

12 December 2020

Emergence of resistance to ceftazidime during therapy for Enterobacter cloacae infections

1 reference

12 December 2020

Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin

1 reference

12 December 2020

Combination effect of azthreonam with four aminoglycosides on nosocomial gram-positive cocci and non-fermenting gram-negative bacteria.

1 reference

12 December 2020

Safety, tolerance, and pharmacokinetic evaluation of cefepime after administration of single intravenous doses

1 reference

12 December 2020

Comparative in vitro activity of cefepime (BMY 28142) against multiresistant nosocomial isolates of Pseudomonas aeruginosa.

1 reference

12 December 2020

Activity of cefepime (BMY-28142) and cefpirome (HR 810) against gram-negative bacilli resistant to cefotaxime or ceftazidime

1 reference

12 December 2020

An underestimated nosocomial pathogen, Acinetobacter calcoaceticus.

1 reference

12 December 2020

In vitro activity of BMY-28142 in comparison with those of other beta-lactam antimicrobial agents

1 reference

12 December 2020

In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains

1 reference

12 December 2020

HR 810 and BMY-28142, two new cephalosporins with broad-spectrum activity: an in-vitro comparison with other beta-lactam antibiotics

1 reference

12 December 2020

Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the Future

1 reference

12 December 2020

Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for class I beta-lactamase

1 reference

12 December 2020